STOCK TITAN

Sol-Gel Technologies: Great Point reports 7.3% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Sol-Gel Technologies Ltd. (SLGL) is the issuer named in an amended Schedule 13G reporting that Great Point Partners, LLC, investment manager to two funds, and its Senior Managing Member Dr. Jeffrey R. Jay, M.D., and Managing Director Ms. Lillian Nordahl each report shared voting and dispositive power over 239,159 ordinary shares, or 7.30%. The reported event date is September 30, 2026.

Biomedical Value Fund, L.P. is the record holder of 157,843 shares, and Biomedical Offshore Value Fund, Ltd. is the record holder of 81,316 shares. The three reporting persons disclaim beneficial ownership of those shares except to the extent of their respective pecuniary interests. The 7.30% calculation uses 3,273,999 shares outstanding, as reported by SLGL on August 20, 2026.

Beneficially owned shares 239,159 shares Reported by each of the three reporting persons; shared voting and dispositive power
Percent of class 7.30% Reported by each reporting person
BVF record-held shares 157,843 shares Held of record by Biomedical Value Fund, L.P.
BOVF record-held shares 81,316 shares Held of record by Biomedical Offshore Value Fund, Ltd.
Shares outstanding 3,273,999 shares As reported by SLGL on August 20, 2026; used as the basis for the reported percentage
beneficial ownership financial
"disclaim beneficial ownership of the BVF Shares and the BOVF Shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power financial
"Shared Voting Power 239,159.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 239,159.00"
pecuniary interests financial
"except to the extent of their respective pecuniary interests"
investment manager financial
"Great Point is the investment manager of BOVF"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SLGL shares do the reporting persons report owning?

Each of the three reporting persons is reported as beneficially owning 239,159 SLGL ordinary shares, or 7.30%, with shared voting and dispositive power. The reported event date is September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





M8694L137

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Great Point Partners, LLC
Signature:/s/ Dr. Jeffrey R. Jay, M.D
Name/Title:Dr. Jeffrey R. Jay, M.D - Senior Managing Member
Date:11/16/2026
Dr. Jeffrey R. Jay, M.D.
Signature:/s/ Dr. Jeffrey R. Jay, M.D
Name/Title:Dr. Jeffrey R. Jay, M.D
Date:11/16/2026
Ms. Lillian Nordahl
Signature:/s/ Ms. Lillian Nordahl
Name/Title:Ms. Lillian Nordahl
Date:11/16/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned hereby agree as follows: (i) Each of them is individually eligible to use the SCHEDULE 13G to which this Exhibit is attached, and such SCHEDULE 13G is filed on behalf of each of them; and (ii) Each of them is responsible for the timely filing of such SCHEDULE 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. Dated: November 16, 2026 Great Point Partners, LLC By: /s/ Dr. Jeffrey R. Jay, M.D. Dr. Jeffrey R. Jay, M.D., as Senior Managing Member Dr. Jeffrey R. Jay, M.D. By: /s/ Dr. Jeffrey R. Jay, M.D. Dr. Jeffrey R. Jay, M.D. Ms. Lillian Nordahl By: /s/ Ms. Lillian Nordahl Ms. Lillian Nordahl

Keep reading